Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Agilent to Sponsor Global Forensics Congress in Portugal

Published: Tuesday, August 27, 2013
Last Updated: Tuesday, August 27, 2013
Bookmark and Share
Latest LC, GC, MS and mobile-measurement solutions to be featured at September event.

Agilent Technologies Inc. has announced that it will host a series of scientific presentations at the annual meeting of the International Association of Forensic Toxicologists (TIAFT), Sept. 2-6, in Madeira, Portugal.

TIAFT is a prominent international forensics trade association. Its annual congress draws hundreds of forensic and analytical toxicologists from all over the world.

“For over a decade, Agilent has been a proud sponsor of TIAFT’s international meetings and the association’s mission to promote education, training and research in forensic toxicology and related disciplines,” said Tom Gluodenis, Agilent’s global marketing manager of Forensics and Toxicology. “We are pleased to continue our support for this forum highlighting the latest advances in measurement technology.”

Agilent Program Highlights

Tuesday evening keynote address: “Analytical Identification - At the Core of the EU Early Warning System,” presented by Dr. Andrew Cunningham of the European Monitoring Centre for Drugs & Drug Addiction, Lisbon.

Wednesday technical presentation: “Latest Advances in GC/MS, LC/MS, Spectroscopy and Sample-Preparation Technologies for Isometric/Designer Drugs, Drug Metabolite Analysis and Trace Metal Analysis,” presented by Agilent scientists Bernhard Wüest, Juan Aybar, Jaume Morales, Dr. Amparo Villar and Laure Blanc.

Poster presentation: “Ethylglucuronide Determination in Hair as an Indicator of Chronic Alcohol Abuse - A Fully Validated Method in GC-EI-MS/MS,” presented by Dr. Jennifer Pascali, DTOLabs (Agilent authorized partner laboratory), Resana, Italy, and Dr. Franco Tagliaro, Department of Public Health and Community Medicine, Section of Forensic Medicine, University of Verona, Verona, Italy.

Attendees are also invited to visit Agilent’s exhibit (Booth No. 1) to talk with scientists and view the company’s latest advances in sample-preparation technology, chromatography, spectrometry and mobile-measurement solutions for use in forensic toxicology, anti-doping initiatives and related applications.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent Technologies Launches New Products for Analyzing Biotherapeutics
Expanded AdvanceBio portfolio enables scientists to speed research and lower costs.
Thursday, June 25, 2015
Agilent’s Thought Leader Award Supports Dr. Paul Watkins
Dr. Watkins has received the award in recognition of his ongoing work developing integrated methods to predict DILI.
Thursday, January 23, 2014
Agilent Technologies to Separate into Two Public Companies
Life sciences, diagnostics and applied markets (LDA) that will retain the Agilent name, and the other company will be comprised of Agilent's electronic measurement (EM) products.
Monday, September 23, 2013
Dr. Emmanuel Barillot Receives Agilent Thought Leader Award
Award will support Dr. Barillot’s Web-based tools for cancer and drug-safety research.
Friday, August 30, 2013
Agilent Technologies and Ameritox Form Collaboration
Agilent Technologies Inc. and AmeritoxSM announced that they have formed a research collaboration that could accelerate analysis in the field of medication monitoring.
Tuesday, February 12, 2013
Agilent Supports Russell Thomas’ Research at the Hamner Institutes for Health Sciences
Russell supported for his work developing methods to predict drug-induced liver injury.
Thursday, December 08, 2011
Agilent Technologies’ LC/MS Manufacturing Achieves ISO 13485 Certification
6100 Series single quadrupole and 6400 Series triple quadrupole systems now manufactured under ISO 13485 certification.
Monday, September 12, 2011
Agilent Technologies Collaborates with UC Davis on Breakthrough Food-Safety Research
Technology aims to revolutionize food safety by reducing identification time of food-borne bacteria.
Thursday, December 09, 2010
Agilent and Johns Hopkins to Research Toxicity Pathways for Embryonic Brain Development Using Metabolomics
The work could help identify possible contributions of chemicals to disorders such as autism and attention hyperactivity disorders.
Friday, August 20, 2010
BIOCIUS and Agilent Launch High-throughput, RapidFire® Mass Solution for Drug Discovery
Advanced, integrated system for high quality in vitro ADME analysis unveiled at ASMS Conference, May 23-May 27.
Friday, May 21, 2010
Automatic Productivity for Life Science Discovery
Agilent Automation Solutions has announced a 12-page brochure 'Automatic productivity for life science discovery.'
Friday, March 26, 2010
Agilent and the National Center for Food Safety and Technology Collaborate to Develop Food Testing Methods
The collaboration will develop new scientific methods for food testing to solve problems facing global food supply chains.
Wednesday, March 03, 2010
Phytronix and Agilent to Co-Market Phytronix LDTD Ion Source with Agilent Mass Spectrometers
The non-exclusive co-marketing agreement aims to promote the Phytronix Laser Diode Thermal Desorption Ion Source with Agilent mass spectrometers.
Wednesday, June 10, 2009
Regulators OK Agilent buy of Stratagene
Federal Antitrust Regulators Approve Agilent's Purchase of Stratagene
Monday, May 14, 2007
FDA Selects Agilent’s Dual-Mode Platform for MAQC Project
FDA will use Agilent’s dual-mode platform for pharmacogenomics and toxicogenomics studies.
Friday, January 13, 2006
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Using Drug-Susceptible Parasites to Fight Drug Resistance
Researchers at the University of Georgia have developed a model for evaluating a potential new strategy in the fight against drug-resistant diseases.
Boosting Breast Cancer Treatment
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
How Cells ‘Climb’ to Build Fruit Fly Tracheas
Mipp1 protein helps cells sprout “fingers” for gripping.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos